New UNC laboratory to help track and control tropical diseases

September 25th, 2008 by

admin

(University of North Carolina at Chapel Hill) The University of North Carolina at Chapel Hill School of Public Health has ingrained a newborn Gillings Innovation Lab to road and transpose equatorial communicable diseases much as malaria, using state-of-the-art molecular and demographic methods.

Tags: Health

Posted in Infectology |

Related posts

Comments are closed.

Recent Posts

Low-grade gliomas in adults
Anaplastic oligodendroglioma
New fifth edition serum-free light chain analysis
Final data from phase 1 investigator-sponsored trial of oncophage® cancer vaccine in glioma presented at the society for neuro-oncology’s annual meeting
Human bre1 is an e3 ubiquitin ligase for ebp1 tumor suppressor.
A pilot study of human interferon {beta} gene therapy for patients with advanced melanoma by in vivo transduction using cationic liposomes
Bax and bid act in synergy to bring about t11ts-mediated glioma apoptosis via the release of mitochondrial cytochrome c and subsequent caspase activation
Free teleconference on latest glioma treatments: a program for patients and families presented by: dr. howard fine
Gamma-secretase represents a therapeutic target for the treatment of invasive glioma mediated by the p75 neurotrophin receptor
In vitro antitumor mechanisms of various scutellaria extracts and constituent flavonoids

Categories

Archives:

Search: